Skip to main content
  • Registry Web Portal Oculoplastic Outcome EHR-IRIS Integration

    Copyright


    Add to My Bookmarks

    The measures listed below have been developed by the H. Dunbar Hoskins Jr. MD Center for Quality Eye Care of the American Academy of Ophthalmology. The measures are not a clinical guideline and do not establish a medical standard. They have not been tested in all possible applications.

    The measures, while copyrighted, can be reproduced and distributed with appropriate credit, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. The American Academy of Ophthalmology encourages use of the measure by other health care professionals, where applicable.

    Commercial use is defined as the sale, license or distribution of the measures for commercial gain, or incorporation of some or all of a measure into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the measures require a license agreement between the user and the American Academy of Ophthalmology. Neither the Academy nor its members shall be responsible for any use of the measures.

    THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS,” WITHOUT WARRANTY OF ANY KIND.

    © 2019 American Academy of Ophthalmology. All rights reserved. Limited proprietary coding from Current Procedural Terminology (CPT®) is contained in the measures specifications. Users of this code set should obtain all necessary licenses. The Academy disclaims all liability for use or accuracy of the coding contained in these measure specifications. CPT® contained in the measures specifications is copyright 2004-2017 American Medical Association.

    Measures

    Please note, measures listed with * are not currently included in the Centers for Medicare & Medicaid Services Merit Based Incentive Payment System (MIPS) or are not available in the IRIS® Registry (Intelligent Research in Sight) for MIPS reporting.

    Acquired Involutional Entropion -  Normalized Lid Position After Surgical Repair
    Acute Anterior Uveitis - Post-treatment Grade 0 anterior chamber cells*
    Acute Anterior Uveitis - Post-treatment visual acuity*
    Adenoviral Conjunctivitis:  Avoidance of Antibiotics*
    Adult Primary Rhegmatogenous Retinal Detachment Surgery:  No Return to the Operating Room within 90 Days of Surgery
    Adult Primary Rhegmatogenous Retinal Detachment: Visual Acuity Improvement within 90 Days of Surgery
    Surgery for Acquired Involutional Ptosis - Patients with an Improvement of Marginal Reflex Distance
    Adult Surgical Esotropia – Postoperative Alignment
    Adverse Events After Cataract Surgery
    Age-related Macular Degeneration:  Counseling on Antioxidant Supplement*
    Age-related Macular Degeneration:  Dilated Macular Examination
    Age-Related Macular Degeneration: Disease Progression*
    Amblyopia - Interocular Visual Acuity
    Avoidance of Genetic Testing for Age-related Macular Degeneration*
    Avoidance of Preoperative Medical Testing for Cataract Surgery*
    Cataract Surgery Difference between Planned and Final Refraction
    Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy)
    Cataracts: patient satisfaction within 90 days after cataract surgery*
    Cataracts:  Comprehensive Pre-operative Assessment for Cataract Surgery with Intraocular Lens (IOL) Placement*
    Cataracts:  improvement in patient's visual function within 90 days after cataract surgery*
    Chronic Anterior Uveitis -  Post-treatment visual acuity
    Chronic Anterior Uveitis - Post-treatment Grade 0 anterior chamber cells*
    Diabetic Macular Edema - Loss of Visual Acuity
    Endothelial Keratoplasty: Post-operative improvement in best corrected visual acuity to 20/40 or greater (better)
    Endothelial Keratoplasty – Dislocation Requiring Surgical Intervention*
    Epiretinal Membrane:  Anatomic restoration of the retina*
    Evidence of anatomic closure of macular hole within 90 days after surgery as documented by OCT
    Exudative Age-Related Macular Degeneration - Loss of Visual Acuity
    Giant Cell Arteritis:  Absence of fellow eye involvement after treatment
    Glaucoma -  Intraocular Pressure (IOP) Reduction
    Glaucoma - Intraocular Pressure Reduction Following Laser Trabeculoplasty
    Glaucoma - Visual Field Progression in Glaucoma
    Idiopathic Intracranial Hypertension:  No worsening or improvement of mean deviation*
    Improved visual acuity after epiretinal membrane treatment within 120 days
    Improvement of Macular Edema in Patients with Uveitis
    Intraocular Pressure Reduction Following Trabeculectomy or an Aqueous Shunt Procedure
    Intravitreal Injections: Avoidance of Routine Antibiotic Use*
    Nonexudative Age-Related Macular Degeneration - Loss of Visual Acuity*
    Ocular Myasthenia Gravis:  Improvement of ocular deviation or absence of diplopia or functional improvement
    Post-operative opioid management following oculoplastic surgery
    Primary open-Angle Glaucoma:  Counseling on glaucoma*
    Primary Open-angle Glaucoma:  Reduction of intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care
    Refractive Surgery:  Patients with a postoperative correction within + 0.5 Diopter of the Intended Correction
    Refractive Surgery: Patients with a postoperative uncorrected Visual Acuity of 20/20 or better
    Regaining Vision After Cataract Surgery
    Return to OR or endophthalmitis within 90 days after epiretinal membrane surgical treatment
    Return to OR or endophthalmitis within 90 days after macular hole surgery
    Surgical Pediatric Esotropia - Postoperative AlignmentVisual Acuity Improvement Following Cataract Surgery Combined with a Trabeculectomy or an Aqueous Shunt Procedure